AddLife AB: insider trades · Finland · FIN-FSA FI:addlife-ab SE0014401378 FI FI · FIN-FSA Mcap 17.3Bn€ Healthcare
Discover the full directors' dealings record of AddLife AB, a publicly traded company based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, AddLife AB has logged 14 reports. Market capitalisation: €17.3bn. The latest transaction was disclosed on 8 May 2026 — Purchase. Among the most active insiders: Fredrik Dalborg. All data is free.
€252,291
12 ops.
Buy Volume
Financial data FY ended December 2025 · cache
Analyst consensus
3 analysts · 177.00 € Target 193.00 €(+36%) 205.00 €
Income statement
Revenue 10.44 Bn€
Gross profit 3.98 Bn€ 38% margin
Net income 560.0 M€ 5.5% margin
Valuation
PER (trailing) 30.6x
P/Book 3.1x
Beta 1.57
Balance sheet & cash
Market cap 17.33 Bn€
Total debt 4.77 Bn€
Free Cash Flow 1.11 Bn€
Debt / Equity 85%
Profitability & ownership
ROE 10.6%
ROA 4.1%
% insiders 5.2%
% institutions 70.9%
Last declaration on 8 May 2026
Declarations 14 total
Executives ● Purchase28 FIN-FSA
€71,616 5,500 shares @ €13.0211 0.0004% mcap 36.5% of flow SE0014401378⌘
Aktie
FI:A003Y307-1 · 8 May 2026
Ideal exit: 2 Feb 2027 (T+270) Executives ● Purchase25 FIN-FSA
€2,595 200 shares @ €12.975 0.0000% mcap 9.9% of flow SE0014401378⌘
Aktie
FI:A003W180-1 · 18 Feb 2026
Ideal exit: 15 Nov 2026 (T+270) Executives ● Purchase17 FIN-FSA
€26,190 2,000 shares @ €13.0949 0.0002% mcap 100.0% of flow SE0014401378⌘
Aktie
FI:A003V888-1 · 11 Feb 2026
Ideal exit: 8 Nov 2026 (T+270) Executives ● Purchase25 FIN-FSA
€14,039 1,000 shares @ €14.0387 0.0001% mcap 7.2% of flow SE0014401378⌘
Aktie
FI:A003V702-1 · 6 Feb 2026
Ideal exit: 3 Nov 2026 (T+270) Executives ● Purchase35 FIN-FSA
€9,107 549 shares @ €16.5886 0.0001% mcap 34.8% of flow SE0007982814⌘
Aktie
FI:A003U478-1 · 5 Dec 2025
Ideal exit: 1 Sept 2026 (T+270) Executives ● Purchase28 FIN-FSA
€13,242 800 shares @ €16.5521 0.0001% mcap 6.8% of flow SE0014401378⌘
Aktie
FI:A003U450-1 · 5 Dec 2025
Ideal exit: 1 Sept 2026 (T+270) Executives ● Sale17 FIN-FSA
€5,139 300 shares @ €17.1316 0.0000% mcap 100.0% of flow SE0014401378⌘
Aktie
FI:A003T578-1 · 11 Nov 2025
Executives ● Purchase22 FIN-FSA
€1,789 115 shares @ €15.56 0.0000% mcap 6.8% of flow SE0014401378⌘
Aktie
FI:A003R186-1 · 29 Jul 2025
Ideal exit: 25 Apr 2026 (T+270) Executives ● Purchase25 FIN-FSA
€18,399 1,200 shares @ €15.3325 0.0001% mcap 9.4% of flow SE0014401378⌘
Aktie
FI:A003Q694-1 · 16 Jul 2025
Ideal exit: 12 Apr 2026 (T+270) Executives ● Other17 FIN-FSA
€136,487 7,713 shares @ €17.6957 0.0008% mcap 100.0% of flow SE0014401378⌘
Aktie
FI:A003P546-1 · 9 Jun 2025
Executives ● Purchase32 FIN-FSA
€436 25 shares @ €17.4561 0.0000% mcap 100.0% of flow SE0014401378⌘
Aktie
FI:A003P357-1 · 5 Jun 2025
Ideal exit: 2 Mar 2026 (T+270) Executives ● Purchase28 FIN-FSA
€78,749 4,500 shares @ €17.4998 0.0005% mcap 40.2% of flow SE0014401378⌘
Aktie
FI:A003P351-1 · 5 Jun 2025
Ideal exit: 2 Mar 2026 (T+270) Executives ● Purchase32 FIN-FSA
€3,412 200 shares @ €17.0621 0.0000% mcap 100.0% of flow SE0014401378⌘
Aktie
FI:A003P348-1 · 4 Jun 2025
Ideal exit: 1 Mar 2026 (T+270) Executives ● Purchase26 FIN-FSA
€12,716 750 shares @ €16.9547 0.0001% mcap 48.5% of flow SE0014401378⌘
Aktie
FI:A003P104-1 · 27 May 2025
Ideal exit: 21 Feb 2026 (T+270)